Third Avenue Management’s Largest 4 Healthcare Stocks: TFX, PPDI, PPD, HAE, SNY

Wall St. Watchdog reveals information regarding Third Avenue Management’s top holdings in the Healthcare sector for the quarter ending September 30th, 2011. The firm held 4 stocks in the Healthcare sector at the end of the quarter with an aggregate market value of $2.914 million.

  • Teleflex Incorporated (NYSE:TFX): On 06/30/2011, Third Avenue Management reported holding 7,924 shares with a market value of $483,839. This comprised 0.25% of the total portfolio. On 09/30/2011, Third Avenue Management reported holding 30,773 shares with a market value of $1,654,664. This comprised 1.29% of the total portfolio. The net change in shares for this position over the two quarters is 22,849. About Company: Teleflex Incorporated is a global provider of medical technology products. The Company primarily develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications.
  • Pharmaceutical Product Development Inc. (NASDAQ:PPDI): On 06/30/2011, Third Avenue Management reported holding 72,062 shares with a market value of $1,934,144. This comprised 1% of the total portfolio. On 09/30/2011, Third Avenue Management reported holding 44,683 shares with a market value of $1,146,566. This comprised 0.9% of the total portfolio. The net change in shares for this position over the two quarters is -27,379. About Company: Pharmaceutical Product Development, Inc. (NYSE:PPD) offers drug discovery and development services to pharmaceutical, biotechnology, and medical device companies. The Company conducts pre-clinical programs and phase I to phase IV clinical trials. For approved drugs, PPD offers product launch services, and patient compliance and medical communications programs.
  • Haemonetics Corp. (NYSE:HAE): On 06/30/2011, Third Avenue Management reported holding 0 shares. On 09/30/2011, Third Avenue Management reported holding 1,549 shares with a market value of $90,586. This comprised 0.07% of the total portfolio. The net change in shares for this position over the two quarters is 1,549. About Company: Haemonetics Corporation designs, manufactures, and markets automated blood processing systems. The Company’s products are for use in surgical blood salvage, blood component collections, and plasma collections. Haemonetics markets its products worldwide, primarily outside the United States.
  • Sanofi-aventis (NYSE:SNY): On 06/30/2011, Third Avenue Management reported holding 875 shares with a market value of $35,149. This comprised 0.02% of the total portfolio. On 09/30/2011, Third Avenue Management reported holding 690 shares with a market value of $22,632. This comprised 0.02% of the total portfolio. The net change in shares for this position over the two quarters is -185. About Company: Sanofi-Aventis is a global pharmaceutical company that researches, develops and manufactures prescription pharmaceuticals and vaccines. The Company develops cardiovascular, thrombosis, metabolic disorder, central nervous system, internal medicine and oncology drugs, and vaccines.

(Note: Data regarding Third Avenue Management’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>